Krystexxa 8 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FX1PF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,903
Award facts
- Contract value 100% obligated
- $55,903.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $55,903.32 firm fixed-price order is for the supply of Krystexxa (pegloticase) 8 mg/mL injectable medication, a biologic used to treat gout. The contract has an ultimate completion date of January 3, 2025.
DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for various pharmaceutical products through November 2026.
Quick answers
Who was awarded contract SPE2DB25FX1PF?
SPE2DB25FX1PF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2024.
How much is contract SPE2DB25FX1PF worth?
The government has obligated $55,903 on SPE2DB25FX1PF.
Is contract SPE2DB25FX1PF an order under another contract?
Yes. SPE2DB25FX1PF is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1PF competed?
The extent of competition for SPE2DB25FX1PF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award